Open AccessShort‐term cost‐effectiveness of one‐stage implant‐based breast reconstruction with an acellular dermal matrix versus two‐stage expander‐implant reconstruction from a multicentre randomized clinical trial
Author(s) -
Negenborn V. L.,
Smit J. M.,
Dikmans R. E. G.,
Winters H. A. H.,
Twisk J. W. R.,
Ruhé P. Q.,
Mureau M. A. M.,
Tuinder S.,
Eltahir Y.,
Posch N. A. S.,
van SteveninckBarends J. M.,
van der Hulst R. R. W. J.,
Ritt M. J. P. F.,
Bouman M.B.,
Mullender M. G.
Publication year - 2019
Publication title -
british journal of surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.202
H-Index - 201
eISSN - 1365-2168
pISSN - 0007-1323
DOI - 10.1002/bjs.11102
Subject(s) - medicine , breast reconstruction , stage (stratigraphy) , implant , surgery , randomized controlled trial , mastectomy , tissue expander , breast surgery , clinical trial , breast cancer , cancer , paleontology , biology
Implant-based breast reconstruction (IBBR) is the most commonly performed reconstructive procedure and its economic impact is significant. This study aimed to analyse whether a direct one-stage IBBR with use of an acellular dermal matrix (ADM) is more cost-effective than two-stage (expander-implant) breast reconstruction.